Acceleration and Innovation in Drug Discovery Through Academic CollaborationTuesday, 22 March 2016 at 11:30  Add to Calendar ▼2016-03-22 11:30:002016-03-22 12:30:00Europe/LondonAcceleration and Innovation in Drug Discovery Through Academic CollaborationAcademic Drug Discovery 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.comThe CTI model of structured and transparent industry-academic collaboration is intended to accelerate the development of novel drugs in a way that leverages the strengths of academic discovery and industry infrastructure. A humanized antibody against Staphylococcal enterotoxin B, a toxin that contributes to the virulence of MRSA and can act as a superantigen and biological warfare agent, was developed and evaluated as a potential therapeutic agent. |
Add to Calendar ▼2016-03-22 00:00:002016-03-23 00:00:00Europe/LondonAcademic Drug Discovery 2016Academic Drug Discovery 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com
.gif)
